Extractables & Leachables : [E & L 2012 conference proceedings] : delivering pharmaceuticals safely : 12-13 December 2012, Vienna, Austria /

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
od: Cook, Arthur G.
Wydane: (2006)

Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Wydane: (2008)

The pharmaceutical studies reader /
Wydane: (2015)

Medicines as a service a new commercial model for big pharma in the postblockbuster world /
od: Mattke, Soeren
Wydane: (2012)

Supply chain management in the drug industry delivering patient value for pharmaceuticals and biologics /
od: Rees, Hedley
Wydane: (2011)

Risk management applications in pharmaceutical and biopharmaceutical manufacturing
Wydane: (2013)

Devalued and distrusted can the pharmaceutical industry restore its broken image? /
od: LaMattina, John L.
Wydane: (2013)

Glocal pharma : international brands and the imagination of local masculinity /
od: Johnson, Ericka
Wydane: (2016)

Portfolio, program, and project management in the pharmaceutical and biotechnology industries
Wydane: (2010)

Pharmaceutical and biomedical project management in a changing global environment
Wydane: (2010)

Leachables and extractables handbook safety evaluation, qualification, and best practices applied to inhalation drug products /
Wydane: (2012)

Understanding drugs markets : an analysis of medicines, regulations, and pharmaceutical systems in the global south /
Wydane: (2022)

Successfully marketing clinical trial results winning in the healthcare business /
od: Umbach, Günter
Wydane: (2006)

Towards drugs of the future key issues in lead finding and lead optimization /
Wydane: (2008)

WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
Wydane: (2003)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
Wydane: (2014)

Pharmaceutical blending and mixing /
Wydane: (2015)

Coherence for health innovation for new medicines for infectious diseases.
Wydane: (2009)

Pharmaceutical pricing policies in a global market
Wydane: (2008)

Pharmaceutical industry innovation and developments /
Wydane: (2011)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Wydane: (2004)

Les prix des medicaments sur un marche global politiques et enjeux.
Wydane: (2008)

Therapeutic targets modulation, inhibition, and activation /
Wydane: (2012)

The agile approach to adaptive research optimizing efficiency in clinical development /
od: Rosenberg, Michael J.
Wydane: (2010)

Building a national framework for the establishment of regulatory science for drug development workshop summary /
Wydane: (2011)

Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
Wydane: (2007)

Pharmaceutical innovation and access to medicines /
Wydane: (2018)

The greening of pharmaceutical engineering. practice, analysis, and methodology /
od: Islam, Rafiqul, 1959-
Wydane: (2015)

Negotiating health : intellectual property and access to medicines /
Wydane: (2006)

Innovation in the biopharmaceutical industry
Wydane: (2007)

The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
Wydane: (2006)

Pharmaceutical lifecycle management making the most of each and every brand /
od: Ellery, Tony
Wydane: (2012)

Organelle-specific pharmaceutical nanotechnology
Wydane: (2010)

Outsourcing clinical development strategies for working with CROs and other partners /
Wydane: (2006)

Emerging safety science workshop summary /
Wydane: (2008)

Analysis of aggregates and particles in protein pharmaceuticals
Wydane: (2012)